The need to access emerging markets with new, cost-effective drugs, the reduction of NCEs that have been introduced to the market, the diminishing Blockbuster product model, and the far more complicated Life Cycle Management programs are just some of the new and ever-changing challenges that innovative pharmaceutical companies face in today's environment.
This is amplified by the increasing cost pressures from Healthcare payers for both governments and health care providers alike.
However, what has remained unchanged in the industry is the need to deliver high-quality, efficacious, and cost-effective medicine to patients while delivering high-value returns to the investors.
Even the emerging markets are demanding access to new and effective treatments at the same time as the rest if the established markets, but at a price which makes the products affordable to them.
CPS is able to help these innovator companies by offering innovative solutions through cost-effective development and manufacturing as well as with cutting edge science. It is by delivering solutions to the problems that the innovators encounter where CPS brings value.
Because of Dr. Reddy's experience in delivering high-quality, cost-effective medicines across the globe, CPS has the proven skill set to help the innovator forge their way through these new and serious challenges. We believe that only through intensified collaborations, we are able to address these external forces.
Regions where services are provided:
Asia, North America, Europe, Latin America.
Outsourcing services provided:
Development and Phase I/II CTM
API Production Technologies